Letrozole in Combination with Trastuzumab Is Superior to Letrozole Monotherapy as First Line Treatment in Patients with Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer (MBC) - Results of the eLEcTRA Trial
Cancer Res
2009
69 Suppl.
24
737S-738S
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Nat Genet
2009
41
5
585-90
Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes?
Breast Care (Basel)
2009
4
2
93-99
Missense mutation in the inducible T-cell kinase (ITK) leading to immunodeficiency and fatal immune dysregulation after EBV infection
Klin Padiatr
2009
221
3
70 -
ARDS as presenting symptom in an infant with CD40L deficiency (Hyper-IgM syndrome Type 1).
Klin Padiatr
2009
221
5
302-4
Prevalence Rates of Pathogenic Mutations in the BRCA1 and BRCA2 Genes in Families with Different Disease Histories: Results from the German Consortium for Hereditary Breast and Ovarian Cancer
Cancer Res
2009
69 Suppl.
24
731S-731S
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
J Natl Cancer Inst
2009
101
14
1012-8
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
J Clin Invest
2009
119
5
1350-8
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet
2009
18
22
4442-56